Back to news

iSpecimen Announces 1-for-6 Reverse Stock Split

Newsfile Corp•19/11/2026•08:00 ET
1

Key Highlights

  • ➤iSpecimen (ISPC) announces a 1-for-6 reverse stock split
  • ➤Split takes effect November 23; split-adjusted trading begins November 24
  • ➤Outstanding shares will fall from 5,789,013 to 964,836
  • ➤Reverse split aims to maintain Nasdaq minimum bid-price compliance
  • ➤Stock options, warrants, and restricted units will be adjusted proportionately

Woburn, Massachusetts--(Newsfile Corp. - November 19, 2026) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of 1-for-6.

The reverse stock split will become effective at 4:30 p.m. Eastern Time on November 23, 2026, and the Company's common stock will begin trading on a split-adjusted basis when the market opens on November 24, 2026. The Company's common stock will continue to trade on the Nasdaq Capital Market ("Nasdaq") under the symbol "ISPC." The new CUSIP number for the Company's common stock following the reverse stock split will be 45032V405. Immediately prior to the effectiveness of the reverse stock split, the Company had 5,789,013 shares of common stock issued and outstanding, which will be reduced to 964,836 shares following the reverse stock split.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in